BCRX Competitors & Alternatives
Compare BioCryst Pharmaceuticals Inc with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
BCRX
Main Stock$9.33
Tradestie Score
60
Market Cap
$1.55B
P/E Ratio
7.9
Revenue Growth
2.1%
Analyst Upside
+128.3%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$348.77
|
$160.70B | 24.8 | 58 | Compare |
|
GILD
Gilead Sciences Inc
|
$134.25
|
$137.92B | 20.2 | 57 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$691.40
|
$46.96B | 35.4 | 56 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$85.68
|
$24.57B | - | 49 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$183.84
|
$22.61B | 21.7 | 62 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$128.32
|
$13.59B | 28.3 | 62 | Compare |
|
EXEL
Exelixis Inc
|
$41.53
|
$11.09B | 15.4 | 62 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$49.56
|
$10.74B | - | 59 | Compare |
|
QGEN
QIAGEN N.V.
|
$39.07
|
$10.04B | 19.5 | 50 | Compare |
|
TECH
Bio-Techne Corp.
|
$50.95
|
$9.33B | 99.4 | 55 | Compare |
More BCRX Analysis
Data updated: Mar 30, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry